Navigation Links
Dr. Brian Mehling Talks Stem Cells at China's Taishan Academic Forum
Date:11/26/2013

NEW YORK, Nov. 26, 2013 /PRNewswire/ -- Dr. Brian Mehling, New York-based orthopedic surgeon and founder of Blue Horizon International, spoke Sunday in Shangdong, China at the 2013 Taishan Academic Forum International Conference on Hematopoietic Stem Cells and Leukemia.

Over 200 Chinese doctors and graduate students also attended the Taishan Academic Forum 2013 International Conference, sponsored by the Weifang Medical University in Shangdong.  They discussed the use of stem cell treatments for chronic conditions and acute diseases, and how such treatments have changed the face of global health care, allopathic medicines and traditional Chinese medicines.

"Stem cell treatments are without a doubt the future of medicine," stated Dr. Mehling.  "It is very important that young doctors learn about the possibilities in stem cell research, and also about the treatments that are already available for patients with different chronic conditions.

Blue Horizon International is a health care consulting company which combines cutting edge medical treatment and research with philanthropy.  BHI provides resources and services to children and adults of all backgrounds, but especially those who are medically underserved.  BHI subsidiaries have successfully performed over 2000 documented stem cell procedures on over 500 patients to date.  For more information please visit Blue Horizon International at www.bluehorizoninternational.com.

Media Contact:
Odd Einer
+1-212-206-0902

PRLog ID: www.prlog.org/12247276


'/>"/>
SOURCE Blue Horizon International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
4. Brian Cousins Joins Opedix Joint Support Athletic Wear as Vice President of Business Development
5. Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Televisions "Taking Stock with Pimm Fox"
6. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
7. Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, and Implications, a New and Upcoming Drug Safety Webinar Hosted by Xtalks
8. Respiratory Update: Interpreting Minimal Clinically Important Differences in COPD and Demonstrating Product Value with PROs, a New Life Science webinar Hosted by Xtalks
9. Pharmacovigilance: ADR Management and Reporting & Outsourcing Trends, A New Drug Safety Webinar from Xtalks
10. Data-driven Site Negotiations: Fast Track to Fair Market Value (FMV), a New Clinical Trials Webinar from Xtalks
11. Market Access and Pipeline Development – How Healthcare Modeling Can Make a Difference, a Pharmaceutical Market Strategy Webinar from Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):